Ceffect 25 mg/ml Suspension for Injection for Cattle and Pigs

Country: United Kingdom

Language: English

Source: VMD (Veterinary Medicines Directorate)

Active ingredient:

Cefquinome

Available from:

Emdoka bvba

ATC code:

QJ01DE90

INN (International Name):

Cefquinome

Pharmaceutical form:

Suspension for injection

Prescription type:

POM-V - Prescription Only Medicine – Veterinarian

Therapeutic group:

Cattle, Pigs

Therapeutic area:

Antimicrobial

Authorization status:

Authorized

Authorization date:

2012-12-18

Summary of Product characteristics

Revised: May 2018
AN: 02472/2017
Page 1 of 7
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Ceffect 25 mg/ml suspension for injection for cattle and pigs
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
1 ml contains:
ACTIVE SUBSTANCE:
Cefquinome (as sulfate)
25 mg
EXCIPIENT(S):
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Suspension for injection.
White to slightly yellowish suspension.
4.
CLINICAL PARTICULARS
4.1. TARGET SPECIES
Cattle and pigs.
4.2. INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the treatment of bacterial infections in cattle and pigs caused by
the Gram
positive and Gram negative microorganisms sensitive to cefquinome.
Cattle:
Respiratory
disease
caused
by
_Pasteurella _
_multocida_
and
_Mannheimia _
_haemolytica._
Digital dermatitis, infectious bulbar necrosis and acute interdigital
necrobacillosis
(foul in the foot).
Acute _E.coli_ mastitis with signs of systemic involvement.
Calves:
_E.coli_ septicaemia in calves.
Pigs:
For the treatment of bacterial infections of the lungs and respiratory
tract caused
by
_Pasteurella _
_multocida, _
_Haemophilus _
_parasuis, _
_Actinobacillus _
_pleuropneumoniae, _
_Streptococcus _
_suis_
and
other
cefquinome-sensitive
organisms.
Revised: May 2018
AN: 02472/2017
Page 2 of 7
Mastitis-Metritis-Agalactia
syndrome
(MMA)
with
involvement
of
_E.coli, _
_Staphylococcus _
spp_., _
_Streptococcus _
spp.
and
other
cefquinome
sensitive
organisms.
Piglets:
Reduction of mortality in cases of meningitis caused by _Streptococcus
suis_.
For the treatment of:
Arthritis caused by _ Streptococcus _ spp_., E. coli_ and other
cefquinome-sensitive
organisms.
Epidermitis (mild or moderate lesions) caused by _Staphylococcus
hyicus._
4.3 CONTRAINDICATIONS
Do not use in case of hypersensitivity to β-lactam antibiotics, or to
any of the
excipients.
Do not administer to animals less than 1.25 kg body weight.
Do not use in poultry (including eggs) due to risk of spread of
antimicrobial
resistance to humans.
4.4 SPECIAL WA